; (B) engaging in activities to develop, advance, and introduce affordable, available, and appropriate global health products; and (C) scaling up appropriate health innovations in the development pipeline. (3) A description of collaboration and coordination with other Federal departments and agencies, including the Centers for Disease Control and Prevention, in support of global health product development, including a description of how the Agency is working to ensure critical gaps in product development for global health are being filled. (4) A description of how the Agency is coordinating and aligning global health innovation activities between the Global Development Lab, the Center for Accelerating Innovation and Impact, and the Bureau for Global Health.